And we haven't even delved into AGC's capacity. I
Post# of 148172
(Total Views: 501)
Posted On: 08/19/2020 12:18:13 AM
And we haven't even delved into AGC's capacity. It's at least 75% of Samsung's current capacity.
Both CMOs are FDA approved/cleared to manufacture Leronlimab. NP has touted that it typically takes a couple of years to get the tech transfer and approvals.
I recently found an article on concerning accelerated mAb development/production due to COVID-19.
https://www.nature.com/articles/s41587-020-0512-5
It's saying that the process time can be cut down in half. Mostly due to overlapping different parts of the processes. This introduces risk, but there are mitigation plans and the benefit far outweighs the risks.
Both CMOs are FDA approved/cleared to manufacture Leronlimab. NP has touted that it typically takes a couple of years to get the tech transfer and approvals.
I recently found an article on concerning accelerated mAb development/production due to COVID-19.
https://www.nature.com/articles/s41587-020-0512-5
It's saying that the process time can be cut down in half. Mostly due to overlapping different parts of the processes. This introduces risk, but there are mitigation plans and the benefit far outweighs the risks.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼